Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Saudi Arabia
/
Pharmaceuticals & Biotech
/
Jamjoom Pharmaceuticals Factory
4015
Jamjoom Pharmaceuticals Factory
Rising MENA Demand And Vision 2030 Investments Will Redefine Markets
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
19 Jul 25
Updated
15 Aug 25
9
Set Fair Value
0
votes
Share
AnalystConsensusTarget
's Fair Value
ر.س178.20
8.8% undervalued
intrinsic discount
15 Aug
ر.س162.60
Loading
1Y
-3.0%
7D
0.06%
Author's Valuation
ر.س178.2
8.8% undervalued
intrinsic discount
AnalystConsensusTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystConsensusTarget Fair Value
ر.س178.2
8.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
2b
2018
2020
2022
2024
2025
2026
2028
Revenue ر.س2.1b
Earnings ر.س605.6m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
10.77%
Pharma revenue growth rate
1.09%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
18.98%
Calculation
ر.س605.58m
Earnings '28
x
34.69x
PE Ratio '28
=
ر.س21.01b
Market Cap '28
ر.س21.01b
Market Cap '28
/
70.00m
No. shares '28
=
ر.س300.14
Share Price '28
ر.س300.14
Share Price '28
Discounted to 2025 @ 18.98% p.a.
=
ر.س178.20
Fair Value '25